
    
      Objective to evaluate the efficacy and safety of maintenance therapy with Chidamide in
      patients With Hepatitis B Virus（HBV）Positive Diffuse Large B-cell Lymphoma（DLBCL） with
      complete response after completion of prior chemotherapy, so as to provide the basis for the
      application of Chidamide in HBV positive DLBCL
    
  